Republican Sen. Thom Tillis from North Carolina suggested Thursday he could support a compromise that would allow the Senate Banking Committee to start hearings on…
For decades, America has told a singular story about success, suggesting that the only acceptable path to success is a four-year degree. Any other trajectory…
A BridgeBio Pharma drug developed for dwarfism increased children’s growth rates in a pivotal clinical trial, meeting the study’s main goal and boosting the daily…
